DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on October 22, 2004; DOI: 10.1124/dmd.104.001321


0090-9556/05/3301-77-82$20.00
DMD 33:77-82, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.104.001321v1
33/1/77    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webb, L. J.
Right arrow Articles by Ritter, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webb, L. J.
Right arrow Articles by Ritter, J. K.

ANALYSIS OF SUBSTRATE SPECIFICITIES AND TISSUE EXPRESSION OF RAT UDP-GLUCURONOSYLTRANSFERASES UGT1A7 AND UGT1A8

Laura J. Webb, Kristini K. Miles, Diana J. Auyeung, Fay K. Kessler, and Joseph K. Ritter

Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia

The UGT1 complex codes for a subfamily of homologous "1A7-like" UDP-glucuronosyltransferases (UGTs), including UGT1A7 and UGT1A8. Little information is available regarding either the substrate specificities or regulation of the UGT1A7-like forms from rats. We compared the activities and tissue expression of UGT1A7 and UGT1A8, which exhibit 77% identity in their amino terminal sequence. UGT1A7 shows broad specificity, catalyzing the glucuronidation of 31 of 40 randomly selected substrates (100 µM) at rates >0.1 nmol/mg/min. UGT1A7 substrates included both planar and nonplanar compounds, mono- and polycyclic aromatics, and compounds with bulky side chain ring substitutions. UGT1A8 exhibited a narrower substrate specificity that completely overlapped with UGT1A7. UGT1A8 was most active toward the 1-OH, 4-OH, 5-OH, 6-OH, 7-OH, 10-OH, 11-OH, and 12-OH derivatives of benzo[a]pyrene. Other effective UGT1A8 substrates (>0.1 nmol/mg/min) included 9-OH-benzo[a]pyrene, 1-naphthol, 4-methylumbelliferone, 7-hydroxycoumarin, chrysin, quercetin, 4-nitrophenol, and estriol. In general, substrates preferred by UGT1A8 were polyaromatic planar structures with nonbulky substituents and a superimposable 1-naphtho ring structure. Studies of the tissue expression of the UGT1A7 and 1A8 mRNAs using RNase protection analysis suggested that each is expressed in liver and kidney of control rats. A major difference is the higher expression of UGT1A7 mRNA in intestine. These studies suggest complementary functions of the UGT1A7 and UGT1A8 forms in xenobiotic metabolism. Further studies are necessary to determine whether their relative contributions change as a function of development, hormonal status, or exposure to inducing agents.


Address correspondence to: Dr. Joseph K. Ritter, Department of Pharmacology and Toxicology, Virginia Commonwealth University, Medical College of Virginia Campus, Box 980613, 410 N 12th St., Richmond, VA 23298-0613. E-mail: jkritter{at}vcu.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
S. T. Stern, M. N. Tallman, K. K. Miles, J. K. Ritter, and P. C. Smith
Androgen Regulation of Renal Uridine Diphosphoglucuronosyltransferase 1A1 in Rats
Drug Metab. Dispos., September 1, 2008; 36(9): 1737 - 1739.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Emi, S.-i. Ikushiro, and Y. Kato
Thyroxine-Metabolizing Rat Uridine Diphosphate-Glucuronosyltransferase 1A7 Is Regulated by Thyroid Hormone Receptor
Endocrinology, December 1, 2007; 148(12): 6124 - 6133.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Matsumoto, H. Iwano, H. Inoue, N. Iwano, N. Yamashiki, and H. Yokota
Metabolic Barrier against Bisphenol A in Rat Uterine Endometrium
Toxicol. Sci., September 1, 2007; 99(1): 118 - 125.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
E. G. van de Kerkhof, I. A. M. de Graaf, M. H. de Jager, and G. M. M. Groothuis
Induction of Phase I and II Drug Metabolism in Rat Small Intestine and Colon in Vitro
Drug Metab. Dispos., June 1, 2007; 35(6): 898 - 907.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. N. Tallman, K. K. Miles, F. K. Kessler, J. N. Nielsen, X. Tian, J. K. Ritter, and P. C. Smith
The Contribution of Intestinal UDP-Glucuronosyltransferases in Modulating 7-Ethyl-10-hydroxy-camptothecin (SN-38)-Induced Gastrointestinal Toxicity in Rats
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 29 - 37.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. K. Miles, F. K. Kessler, P. C. Smith, and J. K. Ritter
Characterization of Rat Intestinal Microsomal UDP-Glucuronosyltransferase Activity toward Mycophenolic Acid
Drug Metab. Dispos., September 1, 2006; 34(9): 1632 - 1639.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. K. Miles, F. K. Kessler, L. J. Webb, P. C. Smith, and J. K. Ritter
Adenovirus-Mediated Gene Therapy to Restore Expression and Functionality of Multiple UDP-Glucuronosyltransferase 1A Enzymes in Gunn Rat Liver
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
K. K. Miles, S. T. Stern, P. C. Smith, F. K. Kessler, S. Ali, and J. K. Ritter
AN INVESTIGATION OF HUMAN AND RAT LIVER MICROSOMAL MYCOPHENOLIC ACID GLUCURONIDATION: EVIDENCE FOR A PRINCIPAL ROLE OF UGT1A ENZYMES AND SPECIES DIFFERENCES IN UGT1A SPECIFICITY
Drug Metab. Dispos., October 1, 2005; 33(10): 1513 - 1520.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.